Pediatrix Medical Group (NYSE:MD) Price Target Raised to $18.50

Pediatrix Medical Group (NYSE:MD - Free Report) had its price target hoisted by UBS Group from $16.50 to $18.50 in a research report sent to investors on Friday morning,Benzinga reports. The brokerage currently has a neutral rating on the stock.

Several other research analysts have also recently commented on the stock. Deutsche Bank Aktiengesellschaft upped their target price on shares of Pediatrix Medical Group from $9.00 to $15.00 and gave the stock a "hold" rating in a research report on Monday, November 4th. Mizuho increased their price objective on Pediatrix Medical Group from $13.00 to $15.00 and gave the stock a "neutral" rating in a report on Tuesday, November 19th. Macquarie started coverage on Pediatrix Medical Group in a research note on Monday, December 16th. They set an "outperform" rating and a $18.00 target price on the stock. Truist Financial boosted their price target on Pediatrix Medical Group from $15.00 to $18.00 and gave the stock a "hold" rating in a research report on Friday. Finally, StockNews.com raised Pediatrix Medical Group from a "hold" rating to a "buy" rating in a report on Wednesday, January 22nd. Four analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Hold" and an average price target of $17.08.

Pediatrix Medical Group Stock Performance

NYSE:MD traded down $0.31 during midday trading on Friday, reaching $15.38. 915,898 shares of the company traded hands, compared to its average volume of 572,436. The firm has a market capitalization of $1.32 billion, a price-to-earnings ratio of -12.81, a price-to-earnings-growth ratio of 1.74 and a beta of 1.57. The company has a fifty day moving average price of $13.92 and a 200 day moving average price of $13.05. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.60 and a quick ratio of 1.42. Pediatrix Medical Group has a twelve month low of $6.62 and a twelve month high of $17.67.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last posted its earnings results on Thursday, February 20th. The company reported $0.49 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.37 by $0.12. The company had revenue of $502.36 million for the quarter, compared to analysts' expectations of $486.22 million. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. On average, analysts expect that Pediatrix Medical Group will post 1.38 EPS for the current fiscal year.

Institutional Investors Weigh In On Pediatrix Medical Group

Several hedge funds and other institutional investors have recently bought and sold shares of the business. Pacer Advisors Inc. acquired a new position in shares of Pediatrix Medical Group in the 4th quarter worth approximately $35,492,000. American Century Companies Inc. grew its position in Pediatrix Medical Group by 628.2% in the fourth quarter. American Century Companies Inc. now owns 1,739,323 shares of the company's stock worth $22,820,000 after buying an additional 1,500,485 shares during the last quarter. Oberweis Asset Management Inc. bought a new position in shares of Pediatrix Medical Group in the fourth quarter valued at $6,122,000. Renaissance Technologies LLC lifted its position in shares of Pediatrix Medical Group by 117.4% during the 4th quarter. Renaissance Technologies LLC now owns 838,800 shares of the company's stock valued at $11,005,000 after acquiring an additional 453,000 shares during the last quarter. Finally, Boston Partners boosted its stake in shares of Pediatrix Medical Group by 25.2% during the 4th quarter. Boston Partners now owns 1,956,353 shares of the company's stock worth $25,922,000 after acquiring an additional 393,600 shares in the last quarter. 97.71% of the stock is currently owned by institutional investors.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.